Referral: Durogesic and associated names
On 21 July 2016, the European Medicines Agency completed a review of Durogesic. The Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that there is a need to harmonise the prescribing information for Durogesic in the European Union (EU).
